Project
Aphinity
Ongoing - recruitment closed · 2012 until 2099
Ruhstaller Thomas, Demmer-Steingruber Ruth, Müller Fiona
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment closed
Start Date
2012
End Date
2099
Financing
Industry
Labels
gynecological tumors
Brief description/objective
A randomized multicenter, double-blind, placebo-controlled comparison of chemotherapy plus trastuzumab plus placebo versus chemotherapy plus trastuzumab plus pertuzumab as adjuvant therapy in patients with operable HER2-positive primary breast cancer (Protocol Roche BO25126)